These authors, by administering Pivagabine (PVG), the drug of choice for the better modulation of the hypothalamic release of CRH, demonstrated that it is possible to modulate the adaptive response to stress and thus restore the menstrual cycle in women diagnosed with FHA. Here, CRH is linked to hypoalphalipoproteinemia, primary, 1.